Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The UNIVERSITY OF WINDSOR currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These cases are split between 2 distinct examiners and 2 distinct art units. This one to one ratio of actions to examiners and units indicates that each pending matter is being treated as a separate technical and administrative effort.
CRAIG D RICCI is the busiest examiner for this portfolio, with 1 busiest examiner pending action assigned to him. The other of the 2 pending office actions is being handled by the second of the 2 distinct examiners. This distribution means that the university must manage two entirely separate dialogues within the Biotechnology & Pharmaceuticals sector.
With 2 distinct art units involved, the prosecution strategy must account for different internal policies and examination trends. The 2 pending office actions represent a focused but divided set of priorities for the institution's intellectual property goals. This structure requires the legal team to maintain specialized knowledge across 2 distinct examiners to successfully advance these applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RICCI, CRAIG D | 1 | 53.8% | +52.5% |
| RUTTEN, JAMES D | 1 | 63.4% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18672179 | Antimicrobial Material Comprising a Tetraalkylphosphonium Ionic Liquid and Metal Nanoparticles | RICCI, CRAIG D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17984612 | Dual State Circuit for Energy Efficient Hardware Implementation of Spiking Neural Networks | RUTTEN, JAMES D | 5d |
| 18672179 | Antimicrobial Material Comprising a Tetraalkylphosphonium Ionic Liquid and Metal Nanoparticles | RICCI, CRAIG D | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 2121 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18672179 | Antimicrobial Material Comprising a Tetraalkylphosphonium Ionic Liquid and Metal Nanoparticles | RICCI, CRAIG D | 1611 | §102§103 | Non-Final OA | — | Pending | May 23, 2024 |
| 17984612 | Dual State Circuit for Energy Efficient Hardware Implementation of Spiking Neural Networks | RUTTEN, JAMES D | 2121 | §103 | Final Rejection | 5d | Pending | Nov 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITY OF WINDSOR has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Craig D Ricci has the most, with 1 of UNIVERSITY OF WINDSOR's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.